ATYR
aTyr Pharma, Inc.
0.305$
-9.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2,707.9% | – | -9,523.4% | – | – | – | – | – | -10,776.8% | – | – | – | -28,705.3% | |
| 281.3% | – | 327.7% | – | – | – | – | – | 204.7% | – | – | – | 832.6% | |
| 188.1% | – | 314.9% | – | – | – | – | – | 687.9% | – | – | – | 2,613.7% | |
| 312.5% | – | -3,230.6% | – | – | – | – | – | 2,150.5% | – | – | – | 556.8% | |
| 157.8% | – | 7.2% | – | – | – | – | – | 19.5% | – | – | – | 146.8% | |
| 1,241.6% | – | -577.0% | – | – | – | – | – | -10,724.7% | – | – | – | 12,043.2% | |
| – | – | – | – | – | – | – | – | 21.1% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -71.6% | – | – | – | -295.8% | |
| 759.8% | – | 3,289.4% | – | – | – | – | – | 15,587.9% | – | – | – | 15,376.3% | |
| -715.6% | – | -6,696.2% | – | – | – | – | – | -5,913.7% | – | – | – | -1,285.8% | |
| -2,865.7% | – | -9,530.6% | – | – | – | – | – | -10,796.3% | – | – | – | -28,852.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.